Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

The End of the Public Health Emergency is (Finally) Here

Client Alert

Dynamic causal modeling for future projection of the COVID-19 pandemic

The COVID-19 Public Health Emergency (“PHE”) that has been in effect for over three years is finally slated to end on May 11, 2023.[1] With the end of the PHE will come many changes for healthcare providers to be aware of; however, some changes may not come until much later.

For example, one of the major changes that came with the PHE was the expansion of coverage for telehealth services rendered to Medicare beneficiaries. These flexibilities are expected to remain in effect through December 31, 2024, thanks to the Consolidated Appropriations Act of 2023.[2]

Upcoming Changes:

However, there are still many changes that will be made following the end of the PHE on May 11. First, unless the Drug Enforcement Agency (“DEA”) implements rules stating otherwise, providers will no longer be able to prescribe controlled substances to patients without first performing an in-person evaluation.[3]

In addition, Medicare Part B beneficiaries, while they will still have coverage for laboratory-conducted COVID-19 tests without cost-sharing, they will no longer have access to free over-the-counter tests.[4] In addition, private insurers will no longer be required to cover tests without cost-sharing (for both over-the-counter and laboratory tests).[5]

Providers will also need to ensure that technology used to perform telemedicine services are HIPAA compliant following the end of the PHE.[6]

Lastly, following the PHE, hospitals treating patients diagnosed with COVID-19 will no longer receive a 20% increase in the Medicare payment rate, and the 3-day prior hospitalization requirement will no longer be waived for Medicare beneficiaries staying at skilled nursing facilities who are transferred for emergencies.[7]

What Will Not Change:

As briefly mentioned above, the Consolidated Appropriations Act of 2023 extended many of the PHE waivers through the end of 2024. Therefore, the following changes are expected to stick around:

  1. Medicare beneficiaries in any geographic area can receive telehealth services, rather than beneficiaries living in rural areas only;
  2. Beneficiaries can remain in their homes for telehealth visits reimbursed by Medicare, rather than needing to travel to a health care facility;
  3. Telehealth visits can be delivered via smartphone in lieu of equipment with both audio and video capability;
  4. An expanded list of Medicare-covered services can be provided via telehealth;
  5. Federally qualified health centers and rural health clinics can provide telehealth services to Medicare beneficiaries (i.e., can be distant site providers), rather than limited to being an originating site provider for telehealth (i.e., where the beneficiary is located).[8]

In addition, certain waivers implemented by the Food and Drug Administration (“FDA”) will also not be affected by the end of the PHE, including the availability of emergency use authorizations (“EUA”) for COVID-19 tests and treatments.[9]

State Law:

As far as Medicaid, many states have implemented their own rules in terms of telehealth flexibilities, and are therefore state-specific.[10] Along the same lines, while some states have created their own waivers for provider licensure requirements, other states have tied the requirements to the PHE. Therefore, providers should be cognizant of state laws as well in terms of the validity of any waivers. 

Conclusion:

Please note that while this Client Alert addresses many of the upcoming changes as a result of the end of the PHE, not all changes are listed. Therefore, we strongly encourage providers to review any waivers they are operating under to see whether they are permanent, and if not, when they are expected to expire.

If you have any questions regarding the expiration of a specific waiver, or any of the above information, please contact BMD Healthcare Member Jeana Singleton or Attorney Rachel Stermer. Jeana can be reached at jmsingleton@bmdllc.com or (330) 253-2001. Rachel can be reached at rcstermer@bmdllc.com or (330) 253-2019. 

 

[1] Kaiser Family Foundation, What Happens When COVID-19 Emergency Declarations End? Implications for Coverage, Costs, and Access, https://www.kff.org/coronavirus-covid-19/issue-brief/what-happens-when-covid-19-emergency-declarations-end-implications-for-coverage-costs-and-access/#medicaid-coverage (Jan. 31, 2023).

[2] Id.

[3] Id.

[4] Department of Health and Human Services, Fact Sheet: COVID-19 Public Health Emergency Transition Roadmap, https://www.hhs.gov/about/news/2023/02/09/fact-sheet-covid-19-public-health-emergency-transition-roadmap.html (Feb. 8, 2023).

[5] Id.

[6] Kaiser Family Foundation.

[7] Id.

[8] Id.

[9] U.S. Food and Drug Administration, FAQs: What happens to EUAs when a public health emergency ends?, https://web.archive.org/web/20230131165732/https:/www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/faqs-what-happens-euas-when-public-health-emergency-ends (Jan. 31, 2023).

[10] Kaiser Family Foundation.


LGBTQIA+ Patients and Discrimination in Healthcare

In early April, the Kaiser Family Foundation released a study outlining the challenges that LGBT adults face in the United States related to healthcare. According to the study, LGBT patients are “twice as likely as non-LGBT adults to report negative experiences while receiving health care in the last three years, including being treated unfairly or with disrespect (33% v. 15%) or having at least one of several other negative experiences with a provider (61% v. 31%), including a provider assuming something about them without asking, suggesting they were personally to blame for a health problem, ignoring a direct request or question, or refusing to prescribe needed pain medication.”

Ohio Recovery Housing Overhaul: New Standards and Certification Requirements Reshape Sober Living Spaces

Ensuring Fair Access: SB 269 Protects Affordable Medication for Low-Income Patients

SB 269, introduced on December 19, 2023, will ensure that 340B covered entities, including Federally Qualified Health Centers, Ryan White Clinics, disproportionate share hospitals, and Title X clinics, can acquire 340B drugs without facing undue restrictions or discriminatory practices from drug manufacturers and distributors. This protection is crucial for 340B covered entities to continue to provide affordable medications and comprehensive services to low-income patients.

Unveiling Ohio's Pharmacy Board Updates for Distributors, Mobile Clinics, and Controlled Substances

The Ohio Board of Pharmacy will hold a public hearing on May 28, 2024, to discuss several proposed changes and additions to Ohio Administrative Code (OAC). These changes pertain to terminal distributors of dangerous drugs (TDDDs), mobile clinics or medication units, and the classification of controlled substances.

House Bill 249: Key Updates to Involuntary Hospitalization Law for Mental Health Providers

House Bill 249 (HB 249) proposes changes to Ohio Revised Code (ORC) Sections 5122.01 and 5122.10 to expand the conditions under which a person with a mental illness can be involuntarily hospitalized.